{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:20:56Z","timestamp":1793830856166,"version":"4.6.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Although patients with blood cancers have the lowest rates of hospice use in oncology, there are sparse data regarding their perceptions of the services that hospice can provide. Lack of transfusion access in hospice has been posited as a key barrier to enrollment; however, data are limited regarding patients\u2019 assessment of the importance of transfusions compared with routine hospice services.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine the importance that patients with blood cancers who are potentially hospice eligible place on access to transfusions compared with routine hospice services.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This multicenter, cross-sectional survey study using a best-worst scaling instrument was conducted from October 1, 2020, to November 1, 2022, at the Dana-Farber Cancer Institute (Boston, Massachusetts) and the Yale Cancer Center (New Haven, Connecticut). Adult patients (aged 18 years or older) diagnosed with blood cancers who had a physician-estimated life expectancy of 6 months or less were included.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The main outcome was the importance that patients placed on routine hospice services (eg, visiting nurse) and nonroutine services (eg, transfusion access) using a best-worst scaling instrument. A hierarchical bayesian multinominal logistic regression of participants\u2019 responses was fit to assess the mean standardized importance score (SIS) for each service.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 331 eligible patients, 200 completed the survey (median age, 70.0 years [IQR, 62.5-76.0 years]; 133 [66.5%] male), with a response rate of 60.4%. The most common diagnosis was leukemia (73 [36.5%]). Transfusion access was considered the most important service (mean SIS, 20.53 [95% CI, 19.42-21.63]), followed by telemedicine (mean SIS, 18.45 [95% CI, 17.33-19.57]). The 3 least important services reported were peer support (mean SIS, 5.06 [95% CI, 4.10-6.02]), social work (mean SIS, 4.35 [95% CI, 3.53-5.16]), and chaplaincy (mean SIS, 1.80 [95% CI, 1.21-2.39]).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this survey study of patients with blood cancers who were potentially hospice eligible, access to blood transfusions had the highest importance relative to routine hospice services. The high value placed on transfusion access suggests that this factor plays a crucial role in hospice decision-making and argues that innovative hospice models that incorporate access to palliative transfusions may increase hospice use and improve end-of-life care for this patient population.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.41719","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:00:46Z","timestamp":1762358446000},"page":"e2541719","source":"Crossref","is-referenced-by-count":8,"title":["Perceived Value of Transfusion Access and Hospice Services Among Patients With Blood Cancers"],"prefix":"10.1001","volume":"8","author":[{"given":"Hari S.","family":"Raman","sequence":"first","affiliation":[{"name":"Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel M.","family":"Cronin","sequence":"additional","affiliation":[{"name":"Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott F.","family":"Huntington","sequence":"additional","affiliation":[{"name":"Yale Cancer Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Uno","sequence":"additional","affiliation":[{"name":"Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Brennan","sequence":"additional","affiliation":[{"name":"Care Dimensions Inc, Boston, Massachusetts"},{"name":"Boston College Connell School of Nursing, Chestnut Hill, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Lysaght","family":"Hurley","sequence":"additional","affiliation":[{"name":"Care Dimensions Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tidswell","sequence":"additional","affiliation":[{"name":"Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Geisel School of Medicine, Dartmouth, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Lanahan","sequence":"additional","affiliation":[{"name":"Transfusion Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly S.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Tulsky","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Abel","sequence":"additional","affiliation":[{"name":"Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"Center for Bioethics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreofe O.","family":"Odejide","sequence":"additional","affiliation":[{"name":"Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"14","key":"zoi251141r1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1001\/jama.300.14.1665","article-title":"Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.","volume":"300","author":"Wright","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"zoi251141r2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jama.291.1.88","article-title":"Family perspectives on end-of-life care at the last place of care.","volume":"291","author":"Teno","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"zoi251141r3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1200\/JCO.2016.68.9257","article-title":"Family perspectives on hospice care experiences of patients with cancer.","volume":"35","author":"Kumar","year":"2017","journal-title":"J Clin Oncol"},{"issue":"29","key":"zoi251141r4","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1200\/JCO.2009.26.3863","article-title":"Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers\u2019 mental health.","volume":"28","author":"Wright","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi251141r5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.JGP.0000194642.86116.ce","article-title":"Length of hospice enrollment and subsequent depression in family caregivers: 13-month follow-up study.","volume":"14","author":"Kris","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"zoi251141r8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv280","article-title":"Hospice use among patients with lymphoma: impact of disease aggressiveness and curability.","volume":"108","author":"Odejide","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"zoi251141r9","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/cncr.29913","article-title":"Intensity of end-of-life care for patients with myelodysplastic syndromes: findings from a large national database.","volume":"122","author":"Fletcher","year":"2016","journal-title":"Cancer"},{"issue":"23","key":"zoi251141r10","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","article-title":"Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?","volume":"26","author":"Earle","year":"2008","journal-title":"J Clin Oncol"},{"issue":"17","key":"zoi251141r11","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1002\/cncr.30735","article-title":"Why are patients with blood cancers more likely to die without hospice?","volume":"123","author":"Odejide","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"zoi251141r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpainsymman.2023.09.024","article-title":"Perspectives on transfusions for hospice patients with blood cancers: a survey of hospice providers.","volume":"67","author":"Knight","year":"2024","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"zoi251141r13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1182\/blood-2018-03-842575","article-title":"Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia.","volume":"132","author":"LeBlanc","year":"2018","journal-title":"Blood"},{"issue":"30","key":"zoi251141r14","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1200\/JCO.2017.72.7149","article-title":"Health care use by older adults with acute myeloid leukemia at the end of life.","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"zoi251141r15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3324\/haematol.2018.187609","article-title":"Meaningful changes in end-of-life care among patients with myeloma.","volume":"103","author":"Odejide","year":"2018","journal-title":"Haematologica"},{"issue":"12","key":"zoi251141r16","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1377\/hlthaff.2012.0286","article-title":"Hospices\u2019 enrollment policies may contribute to underuse of hospice care in the United States.","volume":"31","author":"Aldridge Carlson","year":"2012","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"zoi251141r18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1089\/jpm.2017.0509","article-title":"The surprise question and identification of palliative care needs among hospitalized patients with advanced hematologic or solid malignancies.","volume":"21","author":"Hudson","year":"2018","journal-title":"J Palliat Med"},{"issue":"10","key":"zoi251141r19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jclinepi.2012.04.007","article-title":"The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance.","volume":"65","author":"Moser","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"zoi251141r20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi251141r21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpainsymman.2020.07.025","article-title":"The effect of disclosing life expectancy information on patients\u2019 prognostic understanding: secondary outcomes from a multicenter randomized trial of a palliative chemotherapy educational intervention.","volume":"61","author":"Enzinger","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"zoi251141r22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jpainsymman.2019.12.373","article-title":"Perspectives regarding hospice services and transfusion access: focus groups with blood cancer patients and bereaved caregivers.","volume":"59","author":"Henckel","year":"2020","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"zoi251141r23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40273-016-0429-5","article-title":"Using best-worst scaling to investigate preferences in health care.","volume":"34","author":"Cheung","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"zoi251141r24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3758\/s13428-017-1009-0","article-title":"When is best-worst best? a comparison of best-worst scaling, numeric estimation, and rating scales for collection of semantic norms.","volume":"50","author":"Hollis","year":"2018","journal-title":"Behav Res Methods"},{"issue":"3","key":"zoi251141r25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1017\/S026646231200027X","article-title":"Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies.","volume":"28","author":"Gallego","year":"2012","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"zoi251141r26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1370\/afm.1937","article-title":"Using best-worst scaling to understand patient priorities: a case example of Papanicolaou tests for homeless women.","volume":"14","author":"Wittenberg","year":"2016","journal-title":"Ann Fam Med"},{"issue":"2","key":"zoi251141r27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/1467-842X.00274","article-title":"The use of balanced incomplete block designs in designing randomized response surveys.","volume":"45","author":"Smith","year":"2003","journal-title":"Aust N Z J Stat"},{"issue":"4","key":"zoi251141r30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0095798420930932","article-title":"Latent class analysis: a guide to best practice.","volume":"46","author":"Weller","year":"2020","journal-title":"J Black Psychol"},{"issue":"2","key":"zoi251141r31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/10428194.2012.711830","article-title":"The Functional Assessment of Cancer Therapy-General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma.","volume":"54","author":"Yost","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"zoi251141r32","doi-asserted-by":"publisher","first-page":"11024","DOI":"10.1182\/blood-2022-162527","article-title":"Novel home-based transfusion model of palliative care in malignant hematology.","volume":"140","author":"Saleem","year":"2022","journal-title":"Blood"},{"key":"zoi251141r33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2023-187645","article-title":"Removing transfusion dependence as a barrier to hospice enrollment (BRUOG-407).","volume":"142","author":"Egan","year":"2023","journal-title":"Blood"},{"issue":"4","key":"zoi251141r35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1537-2995.2009.02518.x","article-title":"Activity-based costs of blood transfusions in surgical patients at four hospitals.","volume":"50","author":"Shander","year":"2010","journal-title":"Transfusion"},{"issue":"43","key":"zoi251141r38","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.15585\/mmwr.mm6943a3","article-title":"Trends in the use of telehealth during the emergence of the COVID-19 pandemic\u2014United States, January-March 2020.","volume":"69","author":"Koonin","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"38","key":"zoi251141r39","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1200\/EDBK_200141","article-title":"Telemedicine in cancer care.","volume":"38","author":"Sirintrapun","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"zoi251141r6","year":"2012"},{"key":"zoi251141r7","author":"Goodman","year":"2010"},{"key":"zoi251141r28","author":"de Bekker-Grob","year":"2015"},{"key":"zoi251141r29","year":"2021"},{"key":"zoi251141r34","author":"Medicare program;","year":"2024"},{"key":"zoi251141r37","author":"Improving Access to Transfusion Care for Hospice Patients Act of","year":"2023"},{"key":"zoi251141r17","unstructured":"American Society of Hematology. ASH statement in support of palliative blood transfusions in hospice setting. June 25, 2019. Accessed March 27, 2025. https:\/\/www.hematology.org\/advocacy\/policy-statements\/2019\/palliative-blood-transfusions-in-hospice"},{"key":"zoi251141r36","unstructured":"ASH letter to CMS re FY25 hospice wage index and payment rate update. American Society of Hematology. May 28, 2024. Accessed January 28, 2025. https:\/\/www.hematology.org\/advocacy\/testimony-and-correspondence\/ash-letter-to-cms-re-fy25-hospice-wage-index-and-payment-rate-update"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2840995\/raman_2025_oi_251141_1761766593.03126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:00:47Z","timestamp":1762358447000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2840995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.41719","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}